trans-Dichlorodiamineplatinum(II) structure
|
Common Name | trans-Dichlorodiamineplatinum(II) | ||
---|---|---|---|---|
CAS Number | 14913-33-8 | Molecular Weight | 300.051 | |
Density | 3.746 g/cm3 | Boiling Point | N/A | |
Molecular Formula | H6Cl2N2Pt | Melting Point | 340ºC (dec.) | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS05, GHS08 |
Signal Word | Danger |
Name | transplatin |
---|---|
Synonym | More Synonyms |
Density | 3.746 g/cm3 |
---|---|
Melting Point | 340ºC (dec.) |
Molecular Formula | H6Cl2N2Pt |
Molecular Weight | 300.051 |
Exact Mass | 298.955597 |
PSA | 6.48000 |
LogP | 2.02430 |
Index of Refraction | 1.706 |
Water Solubility | Soluble in dimethylsulfoxide and dimethylformamide. Slightly soluble in water. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS05, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H317-H318-H334 |
Precautionary Statements | P261-P280-P284-P304 + P340-P305 + P351 + P338 + P310 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | T:Toxic; |
Risk Phrases | R23/24/25;R40;R42/43;R68 |
Safety Phrases | S24-S36/37 |
RIDADR | UN 3288 |
WGK Germany | 3 |
RTECS | TP2455000 |
Packaging Group | II |
Hazard Class | 6.1(a) |
TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Oncotarget 5(18) , 8107-22, (2014) p53 plays a key role in regulating DNA damage response by suppressing cell cycle progression or inducing apoptosis depending on extent of DNA damage. However, it is not clear why mild genotoxic stress... |
|
Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
Stem Cells 33(1) , 101-10, (2014) Despite advances in standard therapies, the survival of glioblastoma multiforme (GBM) patients has not improved. Limitations to successful translation of new therapies include poor delivery of systemi... |
|
Crystals of Na(+)/K(+)-ATPase with bound cisplatin.
Biochem. Pharmacol. 92(3) , 494-8, (2014) Cisplatin is the most widely used chemotherapeutics for cancer treatment, however, its administration is connected to inevitable adverse effects. Previous studies suggested that cisplatin is able to i... |
trans--diamminedichloroplatinum(II) |
EINECS 238-980-9 |
trans-diamminodichloroplatinum(II) |
trans-diaminedichloroplatinum(II) |
UNII:Q20Q21Q62J |
Dichloroplatinum diammoniate |
trans-Platinum diammine dichloride |
MFCD00011623 |
CIS-PLATIN |
transplatin |
trans-dichlorodiammineplatinum(II) |
trans-dichlorodiamine platinum(II) |
trans-Dichlorodiamineplatinum(II) |
Cisplatin impurity A |
trans-Diamminedichloroplatinum(II) (trans-Dichlorodiammineplatinum(II) |
cis-Diamminedichlorplatine |